摘要
Objective： To investigate the effect of point injection on post-chemotherapeutic leukopenia. Methods： Three hundred patients were randomly divided into two groups. In the treatment group, 0.6 ml granulocyte colony stimulating factor was injected into bilateral Xuehai （SP 10） and in the control group, the same dose subcutaneously into the deltoid muscle in the upper arm, once daily, three consecutive times as a course of treatment. A peripheral leukocyte count was examined at 3rd, 5th and 7th day after injection. Results and Conclusion： Under three courses of chemotherapy, therewas no significant difference in leukocyte increase between the two methods at 3rd and 5th day after treatment but a leukocyte count was significantly higher at 7th day in the treatment group than in the control group （P〈0.05）. After over half courses of chemotherapy, a peripheral leukocyte count was significantly higher in the treatment group than in the control group （P〈0.05） and it did not rise to the normal at 5-7 days after treatment in the control group. It is showed that point injection raised leukocyte quickly and kept the effect long in comparison with subcutaneous injection and the adverse responses were significantly less in the treatment group than in the control group.
目的:观察穴位注射对肿瘤患者化疗后白细胞减少的影响.方法:将300例患者随机分成两组,治疗组取0.6 ml粒细胞集落刺激因子行双侧血海穴位注射,对照组则取相同剂量行上臂三角肌皮下注射,每日1次,连续3次为1个疗程,并于注射后3、5、7日复查外周血白细胞计数.结果与结论:两种治疗方法对化疗3疗程以内,患者治疗后第3、5日白细胞升高程度无明显差异,而第7日治疗组的白细胞计数明显高于对照组(P＜0.05);化疗疗程过半后,治疗组患者外周血白细胞计数明显高于对照组(P＜0.05),且对照组患者在治疗后5-7 d的细胞计数仍未升至正常.表明穴位注射与皮下注射相比,提升白细胞速度快,维持时间长久,治疗组不良反应明显少于对照组.
